Influence of Local Doxycycline on the Outcomes of Periodontal Regeneration
Periodontal Diseases
About this trial
This is an interventional treatment trial for Periodontal Diseases
Eligibility Criteria
Inclusion Criteria: 1) diagnosis of Stage III or IV periodontitis (Tonetti et al. 2018); 2) FMPS and FMBS < 15% at the time of enrollment; 3) etiological periodontal therapy completed at least 3 months prior to screening; 4) presence of one natural tooth having a vertical defect with residual PPD ≥ 6 mm and a radiographic intrabony component ≥ 3 mm and BoP + requiring periodontal regenerative surgery. Exclusion Criteria: 1) age < 18 years; 2) smoking habits (> 10 cigarettes/day); 3) contraindications for periodontal surgery; 4) systemic diseases affecting periodontal healing; 5) pregnancy and lactation; 6) history of periodontal surgery at the experimental teeth; 7) allergies to doxycycline and tetracyclines; 8) assumption of antibiotics in the last 3 months.
Sites / Locations
- CIR Dental SchoolRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Subgingival instrumentation plus local doxycycline
Subgingival instrumentation alone
Gentle debridement plus local doxycycline administered 2 weeks prior to periodontal regeneration.
Gentle debridement alone performed 2 weeks prior to periodontal regeneration.